Yahoo! Finance Search - Finance Home - Yahoo! - Help

Friday, October 24 2014 10:48pm ET - U.S. Markets Closed.
Industry Center - Drug Delivery
Industry Center > Drug Delivery > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drug Delivery News
Latest News
Thursday, Oct 23, 2014
·Generex / Antigen Express to Participate in 2014 BIO-Europe® Annual International Partnering Conference
PR Newswire - Thu 9:30 am ET
Wednesday, Oct 22, 2014
·Intellipharmaceutics Reports Positive Results from a Series of Phase I Clinical Trials of Regabatin(TM) XR (Pregabalin Extended-Release)
GlobeNewswire - Wed Oct 22
·Alkermes to Host Conference Call to Discuss Third Quarter 2014 Financial Results
Business Wire - Wed Oct 22
·Alkermes’ New Drug Application for Aripiprazole Lauroxil for Treatment of Schizophrenia Accepted for Filing by U.S. FDA
Business Wire - Wed Oct 22
Tuesday, Oct 21, 2014
·Allergan keeps a few secrets, court filing shows
at MarketWatch - Tue Oct 21
·Will This Price Target Increase Help Valeant Pharmaceuticals (VRX) Stock Today?
at TheStreet.com - Tue Oct 21
·Generex Announces Publication of Ebola Vaccine White Paper by Antigen Express
PR Newswire - Tue Oct 21
·Flamel Technologies to Report Third Quarter of Fiscal Year 2014 Results
Marketwire - Tue Oct 21
Monday, Oct 20, 2014
·VALEANT PHARMACEUTICALS INTL (VRX) Earnings Report: Q3 2014 Conference Call Transcript
at TheStreet.com - Mon Oct 20
·PetMed’s results hurt by shortened flea and tick season — seriously?
at MarketWatch - Mon Oct 20
·Allergan files rebuttal to Valeant earnings
at MarketWatch - Mon Oct 20
·Jim Cramer: Valeant Pharmaceuticals and Allergan Are Winners
at TheStreet.com - Mon Oct 20
·[$$] PetMed Posts Lower Earnings
at The Wall Street Journal Online - Mon Oct 20
·[$$] Valeant Pushes Business Strength
at The Wall Street Journal Online - Mon Oct 20
·Strong On High Volume: Valeant Pharmaceuticals International (VRX)
at TheStreet.com - Mon Oct 20
·[video] Cramer's Stop Trading: Valeant & Allergan
at CNBC - Mon Oct 20
·PetMed Express D/B/A 1-800-PetMeds Announces Its Second Quarter Financial Results and Its $0.17 Per Share Quarterly Dividend
GlobeNewswire - Mon Oct 20
·[video] Valeant's bid for Allergan
at CNBC - Mon Oct 20
·[video] Valiant effort by Valeant, Q3 beats estimates
at CNBC - Mon Oct 20
·Valeant Pharmaceuticals Reports Third Quarter 2014 Financial Results
CNW Group - Mon Oct 20
More Latest News...
Sponsor Results
HRP-Based Antibody Arrays
HRP label-based antibody arrays. High sensitivity, many targets!
www.raybiotech.com
United Science QuEChERS
A Better Way to Recover your Planar Pesticides. No Toluene. No kidding.
uniscicorp.com
3DOF Orientation Tracker
Small accurate IMU for 3D measurement of human body segments and more.
xsens.com/mems
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Delivery Headlines
More Finance RSS Feeds


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?